FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2983909233> ?p ?o ?g. }

• W2983909233 endingPage "2019" @default.
• W2983909233 startingPage "00061" @default.
• W2983909233 abstract "Effectiveness studies complement conventional randomised controlled trials by providing a holistic view of treatments in the setting of usual clinical practice. We present the protocol for the ongoing INTREPID (INvestigation of TRelegy Effectiveness: usual PractIce Design; ClinicalTrials.gov identifier: NCT03467425 ) study, a randomised, open-label, 24-week effectiveness study of once-daily fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI; Trelegy) delivered by the ELLIPTA inhaler versus non-ELLIPTA multiple-inhaler triple therapy in patients with chronic obstructive pulmonary disease (COPD) in usual practice settings. INTREPID was designed to provide evidence of FF/UMEC/VI effectiveness in patients with COPD managed in routine healthcare systems across multiple European countries. Between study initiation and end-of-study visits, patients will receive their medication and care as they would ordinarily receive it, from their usual healthcare provider at their usual healthcare centre. Study-specific intervention will be minimal. The primary end-point will be the proportion of COPD assessment test (CAT) responders, defined as a clinically meaningful improvement from baseline of ≥2 units, at week 24. The CAT was chosen as it provides health status information relevant to patients, physicians, health technology agencies and payers. Lung function (forced expiratory volume in 1 s) and critical inhaler errors will also be assessed in a subgroup of patients. The strengths and weaknesses of the protocol and some of the challenges associated with conducting this multicountry study, such as differences in healthcare systems and treatment practices across sites, will also be discussed." @default.
• W2983909233 created "2019-11-22" @default.
• W2983909233 creator A5035463230 @default.
• W2983909233 creator A5038228413 @default.
• W2983909233 creator A5049405030 @default.
• W2983909233 creator A5059390452 @default.
• W2983909233 creator A5059892094 @default.
• W2983909233 creator A5061197238 @default.
• W2983909233 creator A5067253661 @default.
• W2983909233 creator A5067651492 @default.
• W2983909233 creator A5070874744 @default.
• W2983909233 creator A5081646465 @default.
• W2983909233 date "2019-10-01" @default.
• W2983909233 modified "2023-10-16" @default.
• W2983909233 title "Clinical effectiveness of once-daily fluticasone furoate/umeclidinium/vilanterol in usual practice: the COPD INTREPID study design" @default.
• W2983909233 cites W1568214454 @default.
• W2983909233 cites W1768394073 @default.
• W2983909233 cites W1867169352 @default.
• W2983909233 cites W1966235050 @default.
• W2983909233 cites W1984302657 @default.
• W2983909233 cites W1984982865 @default.
• W2983909233 cites W2013350088 @default.
• W2983909233 cites W2024062166 @default.
• W2983909233 cites W2028590696 @default.
• W2983909233 cites W2054371281 @default.
• W2983909233 cites W2062173168 @default.
• W2983909233 cites W2101849970 @default.
• W2983909233 cites W2120729896 @default.
• W2983909233 cites W2125078269 @default.
• W2983909233 cites W2127951128 @default.
• W2983909233 cites W2128659393 @default.
• W2983909233 cites W2132425160 @default.
• W2983909233 cites W2138833643 @default.
• W2983909233 cites W2157968241 @default.
• W2983909233 cites W2159837316 @default.
• W2983909233 cites W2183603474 @default.
• W2983909233 cites W2308810820 @default.
• W2983909233 cites W2343928958 @default.
• W2983909233 cites W2410316792 @default.
• W2983909233 cites W2463140930 @default.
• W2983909233 cites W2506392919 @default.
• W2983909233 cites W2510542619 @default.
• W2983909233 cites W2512624858 @default.
• W2983909233 cites W2558950195 @default.
• W2983909233 cites W2603275790 @default.
• W2983909233 cites W2604577460 @default.
• W2983909233 cites W2613934166 @default.
• W2983909233 cites W2755166569 @default.
• W2983909233 cites W2783521078 @default.
• W2983909233 cites W2802221596 @default.
• W2983909233 cites W2888143498 @default.
• W2983909233 cites W4211263216 @default.
• W2983909233 cites W4240658863 @default.
• W2983909233 cites W4295612440 @default.
• W2983909233 cites W4296605327 @default.
• W2983909233 doi "https://doi.org/10.1183/23120541.00061-2019" @default.
• W2983909233 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6826246" @default.
• W2983909233 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31720293" @default.
• W2983909233 hasPublicationYear "2019" @default.
• W2983909233 type Work @default.
• W2983909233 sameAs 2983909233 @default.
• W2983909233 citedByCount "9" @default.
• W2983909233 countsByYear W29839092332021 @default.
• W2983909233 countsByYear W29839092332022 @default.
• W2983909233 countsByYear W29839092332023 @default.
• W2983909233 crossrefType "journal-article" @default.
• W2983909233 hasAuthorship W2983909233A5035463230 @default.
• W2983909233 hasAuthorship W2983909233A5038228413 @default.
• W2983909233 hasAuthorship W2983909233A5049405030 @default.
• W2983909233 hasAuthorship W2983909233A5059390452 @default.
• W2983909233 hasAuthorship W2983909233A5059892094 @default.
• W2983909233 hasAuthorship W2983909233A5061197238 @default.
• W2983909233 hasAuthorship W2983909233A5067253661 @default.
• W2983909233 hasAuthorship W2983909233A5067651492 @default.
• W2983909233 hasAuthorship W2983909233A5070874744 @default.
• W2983909233 hasAuthorship W2983909233A5081646465 @default.
• W2983909233 hasBestOaLocation W29839092331 @default.
• W2983909233 hasConcept C126322002 @default.
• W2983909233 hasConcept C142724271 @default.
• W2983909233 hasConcept C160735492 @default.
• W2983909233 hasConcept C162324750 @default.
• W2983909233 hasConcept C168563851 @default.
• W2983909233 hasConcept C1862650 @default.
• W2983909233 hasConcept C204787440 @default.
• W2983909233 hasConcept C2776042228 @default.
• W2983909233 hasConcept C2776780178 @default.
• W2983909233 hasConcept C2779028295 @default.
• W2983909233 hasConcept C2780261241 @default.
• W2983909233 hasConcept C2780385302 @default.
• W2983909233 hasConcept C50522688 @default.
• W2983909233 hasConcept C535046627 @default.
• W2983909233 hasConcept C71924100 @default.
• W2983909233 hasConceptScore W2983909233C126322002 @default.
• W2983909233 hasConceptScore W2983909233C142724271 @default.
• W2983909233 hasConceptScore W2983909233C160735492 @default.
• W2983909233 hasConceptScore W2983909233C162324750 @default.
• W2983909233 hasConceptScore W2983909233C168563851 @default.
• W2983909233 hasConceptScore W2983909233C1862650 @default.

• next